Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 7/20 | 1.00 |
| ▸ | POLA1 | P09884 | 2/20 | 0.88 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6666985 | 1.00 | KCNH2 (1.00) | KCNH2POLA1MEN1KMT2AF2 | |
| SCHEMBL6672185 | 0.95 | KCNH2 (0.91) | KCNH2POLA1MEN1KMT2AF2 | |
| SCHEMBL6669876 | 0.94 | KCNH2 (0.89) | KCNH2POLA1MEN1KMT2AF2 | |
| SCHEMBL6706716 | 0.94 | POLA1 (1.00) | KCNH2POLA1MEN1KMT2AF2 | |
| SCHEMBL6706361 | 0.92 | POLA1 (0.94) | KCNH2POLA1MEN1KMT2AF2 | |
| SCHEMBL6708202 | 0.91 | POLA1 (0.91) | KCNH2POLA1MEN1KMT2AF2 | |
| SCHEMBL6668773 | 0.91 | KCNH2 (0.83) | KCNH2POLA1MEN1KMT2AF2 | |
| SCHEMBL6706372 | 0.91 | POLA1 (0.94) | KCNH2POLA1MEN1KMT2AF2 | |
| SCHEMBL6708161 | 0.91 | KCNH2 (0.83) | KCNH2POLA1MEN1KMT2AF2 | |
| SCHEMBL6706433 | 0.90 | KCNH2 (0.87) | KCNH2POLA1MEN1KMT2AF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230136702-A1 | Inhibitors of Human Herpesviruses | THE GOVERNORS OF THE UNIVERSTIY OF ALBERTA (CA) | 2023-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230136702-A1 | Inhibitors of Human Herpesviruses | RPL5, RPL35, HAVCR2 | KCNH2 3695/4885POLA1 690/4885MEN1 1255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.